SemaThera Inc.
Industry
- Pharmaceuticals
- Biotechnology
See more in Biomedtracker
Latest on SemaThera Inc.
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Roche Agrees To Pay $1.8bn For GenMark
Scrip
• By Joseph Haas, Sten Stovall, Anju Ghangurde, Kevin Grogan, and Ian Haydock
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in